Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Shares Outstanding (Weighted Average) (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Shares Outstanding (Weighted Average) data on record, last reported at $20.8 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 355.17% year-over-year to $20.8 million; the TTM value through Sep 2025 reached $20.8 million, up 355.17%, while the annual FY2024 figure was $4.6 million, 3.58% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $20.8 million in Q3 2025 per SNTI's latest filing, down from $26.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $44.1 million in Q1 2023 and bottomed at $2.9 million in Q2 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $11.1 million, with a median of $4.6 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 1289.7% in 2023, then crashed 89.63% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.9 million in 2021, then surged by 796.58% to $26.1 million in 2022, then plummeted by 83.01% to $4.4 million in 2023, then rose by 3.58% to $4.6 million in 2024, then surged by 353.3% to $20.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $20.8 million in Q3 2025, $26.1 million in Q2 2025, and $10.0 million in Q1 2025.